Stock listing

AZN Stock Price, News, Filings & Events — Astrazeneca Plc

Selected listing: AZN · BCBA · ARS · AR

This page tracks Astrazeneca Plc's AZN:BCBA listing on BCBA in ARS for AR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AZN:BCBA. AZN:BCBA is the stock-level entry point for investors researching Astrazeneca Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. AstraZeneca Plc is a publicly traded company listed on the UK market under the ticker AZN. The company has a market capitalization of approximately £261.99 billion. AstraZeneca focuses on the research, development, and commercialization of prescription medicines across various therapeutic areas.

AZN:BCBAARSARUpdated August 14, 2026
Astrazeneca Plc logo
Ticker
AZN:BCBA
Asset type
Stock
Market cap
$244.88B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BCBA
Currency
ARS

Astrazeneca Plc AZN:BCBA stock context

This page tracks Astrazeneca Plc's AZN:BCBA listing on BCBA in ARS for AR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AZN:BCBA. AZN:BCBA is the stock-level entry point for investors researching Astrazeneca Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. AstraZeneca Plc is a publicly traded company listed on the UK market under the ticker AZN. The company has a market capitalization of approximately £261.99 billion. AstraZeneca focuses on the research, development, and commercialization of prescription medicines across various therapeutic areas.

Research Astrazeneca Plc

Alternate listings